Cell Press Supplement: Immunotherapy-Therapeutic Combinations
Combination Immunotherapy the Future of Immuno-Oncology Drug Development
Combination immunotherapy is positioned to be the future of immuno-oncology drug development. Recent research shows that combining cancer immunotherapy with other therapies can produce impressive results particularly in cancers that have shown limited to no response to immunotherapy.
This Research arc supplement by Cell Press provides a collection of articles that highlight different combinatorial approaches. Some of the articles include:
- Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
- Combined Checkpoint Inhibition and Chemotherapy: New Era of 1st Line Treatment of Non Small Cell Lung Cancers
- Glycosylation in the Era of Cancer Targeted Therapy: Where are we heading?
